Development of resistance to BET bromodomain inhibitor JQ1 and demonstration in epithelial-mesenchymal transition in pancreatic cancer cells.

被引：0
|
作者：
Raza, Sania S.
Knab, Mark
Chow, Christina
Kumar, Krishan
Ebine, Kazumi
Munshi, Hidayatullah G.
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15263
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Scalable syntheses of the BET bromodomain inhibitor JQ1
    Syeda, Shameem Sultana
    Jakkaraj, Sudhakar
    Georg, Gunda I.
    TETRAHEDRON LETTERS, 2015, 56 (23) : 3454 - 3457
  • [2] BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells
    Mio, Catia
    Conzatti, Ketty
    Baldan, Federica
    Allegri, Lorenzo
    Sponziello, Marialuisa
    Rosignolo, Francesca
    Russo, Diego
    Filetti, Sebastiano
    Damante, Giusepe
    ONCOLOGY REPORTS, 2018, 39 (02) : 582 - 588
  • [3] Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
    Yamamoto, Keisuke
    Tateishi, Keisuke
    Kudo, Yotaro
    Hoshikawa, Mayumi
    Tanaka, Mariko
    Nakatsuka, Takuma
    Fujiwara, Hiroaki
    Miyabayashi, Koji
    Takahashi, Ryota
    Tanaka, Yasuo
    Ijichi, Hideaki
    Nakai, Yousuke
    Isayama, Hiroyuki
    Morishita, Yasuyuki
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Fukayama, Masashi
    Koike, Kazuhiko
    ONCOTARGET, 2016, 7 (38) : 61469 - 61484
  • [4] THE BET BROMODOMAIN INHIBITOR JQ1 DIMINISHED RENAL FIBROSIS
    Rayego-Mateos, Sandra
    Luis Morgado-Pascual, Jose
    Suarez-Alvarez Suarez-Alvarez, Beatriz
    Orejudo, Macarena
    Rodrigues-Diez, Raul R.
    Marquez-Exposito, Laura
    Egido, Jesus
    Ortiz, Alberto
    Lopez-Larrea, Carlos
    Ruiz-Ortega, Marta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 102 - 102
  • [5] GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1
    Kumar, Krishan
    Raza, Sania S.
    Knab, Lawrence M.
    Chow, Christina R.
    Kwok, Benjamin
    Bentrem, David J.
    Popovic, Relja
    Ebine, Kazumi
    Licht, Jonathan D.
    Munshi, Hidayatullah G.
    SCIENTIFIC REPORTS, 2015, 5
  • [6] The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
    Zhao, Bei
    Cheng, Xiankui
    Zhou, Xiyuan
    MELANOMA RESEARCH, 2018, 28 (06) : 521 - 526
  • [7] GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1
    Krishan Kumar
    Sania S. Raza
    Lawrence M. Knab
    Christina R. Chow
    Benjamin Kwok
    David J. Bentrem
    Relja Popovic
    Kazumi Ebine
    Jonathan D. Licht
    Hidayatullah G. Munshi
    Scientific Reports, 5
  • [8] The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells
    Garcia, Patrick L.
    Miller, Aubrey L.
    Zeng, Ling
    van Waardenburg, Robert C. A. M.
    Yang, Eddy S.
    Yoon, Karina J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer
    Leal, Ana S.
    Williams, Charlotte R.
    Royce, Darlene B.
    Pioli, Patricia A.
    Sporn, Michael B.
    Liby, Karen T.
    CANCER LETTERS, 2017, 394 : 76 - 87
  • [10] Therapeutic effects of the bromodomain inhibitors JQ1 and I-BET 762 on pancreatic cancer
    Leal, Ana S.
    Williams, Charlotte R.
    Sporn, Michael B.
    Liby, Karen T.
    CANCER RESEARCH, 2015, 75
12345